Methyl salicylate 2-O-β-d-lactoside alleviates the pathological progression of pristane-induced systemic lupus erythematosus-like disease in mice via suppression of inflammatory response and signal transduction

Systemic lupus erythematosus (SLE), with a high incidence rate and insufficient therapy worldwide, is a complex disease involving multiple organs characterized primarily by inflammation due to deposition of immunocomplexes formed by production of autoantibodies. The mechanism of SLE remains unclear,...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Yang-Yang, Yan, Yu, Zhang, Hui-Fang, Lin, Yi-Huang, Chen, Yu-Cai, Yan, Yi, Wu, Ping, Fang, Jian-Song, Yang, Shu-Hui, Du, Guan-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047741/
https://www.ncbi.nlm.nih.gov/pubmed/27729775
http://dx.doi.org/10.2147/DDDT.S114501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047741/
https://www.ncbi.nlm.nih.gov/pubmed/27729775
http://dx.doi.org/10.2147/DDDT.S114501

Ejemplares similares